Table 1 Number of incident cases and age-adjusted standardized rates (world population) (ASR-WR) of selected cancers by sex according to calendar period (quinquennia), Sétif Cancer Registry
From: Time trends of cancer incidence in Setif, Algeria, 1986–2010: an observational study
Cancer or group of cancers | Period | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
1986-1990 | 1991-1995 | 1996-2000 | 2001-2005 | 2006-2010 | |||||||
N | ASR-WR/105 | N | ASR-WR/105 | N | ASR-WR/105 | N | ASR-WR/105 | N | % | ASR-WR/105 | |
Men | |||||||||||
Nasopharynx | 78 | 4.5 | 121 | 5.9 | 169 | 7.3 | 170 | 6.4 | 144 | 5.0 | 4.8 |
Stomach | 146 | 9.8 | 131 | 8.1 | 143 | 7.0 | 142 | 6.6 | 159 | 5.5 | 6.1 |
Colon-rectum | 33 | 2.1 | 58 | 3.4 | 136 | 5.9 | 189 | 8.1 | 277 | 9.6 | 9.9 |
Liver | 60 | 4.0 | 36 | 2.3 | 11 | 0.6 | 35 | 1.7 | 53 | 1.8 | 2.1 |
Gallbladder | 30 | 2.0 | 32 | 2.0 | 30 | 1.6 | 60 | 2.9 | 52 | 1.8 | 2.1 |
Larynx | 45 | 3.1 | 55 | 3.6 | 98 | 5.3 | 137 | 6.7 | 153 | 5.3 | 5.9 |
Lung | 181 | 12.7 | 242 | 15.8 | 308 | 17.1 | 414 | 20.2 | 518 | 18.0 | 21.1 |
Prostate | 25 | 1.7 | 39 | 2.6 | 90 | 5.1 | 101 | 4.8 | 188 | 6.5 | 7.6 |
Kidney | 7 | 0.3 | 12 | 0.7 | 17 | 0.7 | 26 | 1.2 | 26 | 0.9 | 0.9 |
Bladder | 25 | 1.6 | 31 | 1.9 | 100 | 5.7 | 164 | 8.1 | 262 | 9.1 | 10.3 |
Thyroid | 5 | 0.3 | 5 | 0.2 | 23 | 1.0 | 31 | 1.2 | 43 | 1.5 | 1.4 |
Hodgkin lymphoma | 43 | 1.8 | 51 | 2.1 | 42 | 1.4 | 103 | 3.3 | 67 | 2.3 | 1.9 |
Non Hodgkin lymphomas | 60 | 3.3 | 80 | 3.9 | 123 | 5.1 | 107 | 4.0 | 158 | 5.5 | 5.2 |
Leukaemias | 119 | 5.1 | 92 | 3.7 | 52 | 2.2 | 63 | 2.4 | 139 | 4.8 | 4.6 |
Unspecified and ill-defined cancers | 86 | 5.4 | 70 | 3.6 | 85 | 4.0 | 76 | 3.0 | 119 | 4.1 | 4.5 |
All cancers but skin | 1118 | 67.9 | 1230 | 69.3 | 1683 | 82.2 | 2136 | 93.3 | 2883 | 100 | 106.4 |
Women | |||||||||||
Nasopharynx | 41 | 2.0 | 60 | 2.7 | 49 | 1.7 | 63 | 2.2 | 69 | 2.1 | 2.1 |
Stomach | 79 | 4.8 | 57 | 3.2 | 64 | 2.7 | 81 | 3.4 | 80 | 2.4 | 2.8 |
Colon-rectum | 39 | 2.4 | 59 | 3.0 | 142 | 6.1 | 213 | 8.6 | 285 | 8.5 | 9.9 |
Liver | 80 | 5.1 | 34 | 2.0 | 18 | 0.9 | 26 | 1.1 | 44 | 1.3 | 1.6 |
Gallbladder | 100 | 6.7 | 150 | 8.8 | 168 | 8.4 | 199 | 9.0 | 149 | 4.4 | 5.7 |
Larynx | 7 | 0.4 | 2 | 0.1 | 3 | 0.1 | 13 | 0.5 | 29 | 0.9 | 0.9 |
Lung | 30 | 2.0 | 34 | 2.0 | 38 | 1.7 | 50 | 2.2 | 121 | 3.6 | 4.5 |
Breast | 192 | 10.6 | 253 | 13.6 | 440 | 20.2 | 571 | 23.1 | 1221 | 36.4 | 39.5 |
Cervix uteri | 156 | 9.3 | 221 | 12.3 | 222 | 11.3 | 239 | 10.7 | 201 | 6.0 | 7.1 |
Corpus uteri | 13 | 0.9 | 16 | 1.0 | 26 | 1.4 | 6 | 0.3 | 8 | 0.2 | 0.3 |
Uterus. unspecified | 12 | 0.8 | 1 | 0.1 | 5 | 0.3 | 14 | 0.6 | 39 | 1.2 | 1.5 |
Ovary | 26 | 1.4 | 45 | 2.3 | 61 | 2.5 | 30 | 1.1 | 75 | 2.2 | 2.2 |
Kidney | 14 | 0.6 | 8 | 0.3 | 28 | 1.0 | 17 | 0.7 | 27 | 0.8 | 1.0 |
Bladder | 3 | 0.2 | 2 | 0.1 | 4 | 0.2 | 50 | 2.2 | 34 | 1.0 | 1.2 |
Thyroid | 22 | 0.9 | 31 | 1.5 | 81 | 3.6 | 145 | 5.4 | 200 | 6.0 | 6.2 |
Hodgkin lymphoma | 24 | 0.9 | 32 | 1.1 | 29 | 0.9 | 63 | 1.6 | 78 | 2.3 | 1.9 |
Non Hodgkin lymphomas | 35 | 1.7 | 46 | 2.1 | 79 | 3.0 | 90 | 3.3 | 112 | 3.3 | 3.4 |
Leukaemias | 77 | 3.5 | 76 | 3.1 | 50 | 1.9 | 56 | 2.1 | 107 | 3.2 | 3.1 |
Unspecified and ill-defined cancers | 77 | 4.2 | 51 | 2.5 | 76 | 3.4 | 76 | 3.0 | 117 | 3.5 | 4.1 |
All cancers but skin | 1143 | 64.4 | 1292 | 67.0 | 1727 | 77.9 | 2190 | 87.8 | 3352 | 100 | 110.3 |